Adverse Drug Reactions (ADRs)
Recognition, management, and reporting of ADRs.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
CKS: Adverse Drug Reactions
National
Guideline For Adverse Drug Reactions (ADRs) Reporting for Healthcare ProfessionalsLocal
ICH Harmonised Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (E2A)Local
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Topic E 2 Clinical Safety Data Management: Definitions and Standards for Expedited ReportingLocal
Send and receive information on adverse drug reactions (ADRs): GuidanceLocal
Severe cutaneous adverse reactions (SCAR): CIOMS Consensus ReportLocal
The Yellow Card scheme: guidance for healthcare professionalsLocal